Indeed, early treatment with an NKG2A-blocking antibody was able to reduce lung metastasis in a mouse model of metastatic pancreatic cancer; however, delivery of NKG2A blockade 3 or 5 days after tumour inoculation still resulted in significant metastasis by day 15 [87]. Here, KLRC1 is linked to familial pancreatic carcinoma.